Biomerica, Inc.
Biomerica, Inc. (BMRA) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · BMRA · as of Jun 8, 2026
Key Statistics
Explore Biomerica, Inc. Data
bmra stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 3 · Buy rate: 100.0%
Competitors & Peers
bmra competitorsBMRA
ALZN
CELZ
HSCS
IINN
LFWDStock Performance
Full HistoryAbout Biomerica, Inc.
Biomerica, Inc. is a biomedical technology firm that invents, secures intellectual property for, produces, and globally distributes diagnostic and therapeutic solutions aimed at identifying and addres…
what is biomerica, inc. · bmra stock overview · biomerica, inc. company profile · who is biomerica, inc. ceo · bmra NASDAQ · biomerica, inc. headquarters · biomerica, inc. business segments
About Stock Overview & Key Data
Biomerica, Inc. (BMRA) is a Healthcare company in the Medical - Devices industry, listed on NASDAQ since Sep 7, 1984. As of the latest trading session, BMRA stock price is $2.07, with a market capitalization of $6.4M. The stock has returned -39.47% over the past 12 months and -17.86% year-to-date.
According to 3 Wall Street analysts, the consensus rating for Biomerica, Inc. stock is Buy, with an average 12-month price target of $—. In fiscal year 2025, Biomerica, Inc. reported revenue of $5.3M and net income of -$5.0M. For detailed data — including Biomerica, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Biomerica, Inc. (BMRA) stock price is $2.07. The stock is traded on NASDAQ under the ticker symbol BMRA. The 52-week range is $1.87 – $4.60.